NO177534C - Analogifremgangsmåte for fremstilling av terapeutisk aktive tricykliske aminer - Google Patents
Analogifremgangsmåte for fremstilling av terapeutisk aktive tricykliske aminerInfo
- Publication number
- NO177534C NO177534C NO910473A NO910473A NO177534C NO 177534 C NO177534 C NO 177534C NO 910473 A NO910473 A NO 910473A NO 910473 A NO910473 A NO 910473A NO 177534 C NO177534 C NO 177534C
- Authority
- NO
- Norway
- Prior art keywords
- preparation
- therapeutically active
- analogous process
- tricyclic amines
- active tricyclic
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
- C07D401/06—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/02—Drugs for disorders of the nervous system for peripheral neuropathies
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
- C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
- C07D405/06—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D409/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
- C07D409/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings
- C07D409/06—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
- C07D487/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
- C07D487/04—Ortho-condensed systems
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
- C07D487/12—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains three hetero rings
- C07D487/14—Ortho-condensed systems
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D495/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms
- C07D495/12—Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms in which the condensed system contains three hetero rings
- C07D495/14—Ortho-condensed systems
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Biomedical Technology (AREA)
- Neurology (AREA)
- Neurosurgery (AREA)
- Pharmacology & Pharmacy (AREA)
- Veterinary Medicine (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- General Chemical & Material Sciences (AREA)
- Hospice & Palliative Care (AREA)
- Psychiatry (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
- Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
- Plural Heterocyclic Compounds (AREA)
- Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
- Indole Compounds (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US47692890A | 1990-02-08 | 1990-02-08 |
Publications (4)
| Publication Number | Publication Date |
|---|---|
| NO910473D0 NO910473D0 (no) | 1991-02-07 |
| NO910473L NO910473L (no) | 1991-08-09 |
| NO177534B NO177534B (no) | 1995-06-26 |
| NO177534C true NO177534C (no) | 1995-10-04 |
Family
ID=23893824
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| NO910473A NO177534C (no) | 1990-02-08 | 1991-02-07 | Analogifremgangsmåte for fremstilling av terapeutisk aktive tricykliske aminer |
Country Status (21)
| Country | Link |
|---|---|
| EP (1) | EP0441517A3 (pl) |
| JP (1) | JPH07119214B2 (pl) |
| KR (1) | KR950013562B1 (pl) |
| CN (1) | CN1054600A (pl) |
| AU (1) | AU631723B2 (pl) |
| BR (1) | BR9100519A (pl) |
| CA (1) | CA2035805C (pl) |
| CS (1) | CS29991A2 (pl) |
| DE (1) | DE9101348U1 (pl) |
| EG (1) | EG19644A (pl) |
| FI (1) | FI910592A (pl) |
| HU (1) | HUT70051A (pl) |
| IE (1) | IE910402A1 (pl) |
| IL (1) | IL97140A (pl) |
| NO (1) | NO177534C (pl) |
| NZ (1) | NZ237040A (pl) |
| PL (2) | PL167078B1 (pl) |
| PT (1) | PT96681A (pl) |
| TW (1) | TW197442B (pl) |
| YU (1) | YU21391A (pl) |
| ZA (1) | ZA91916B (pl) |
Families Citing this family (13)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP2807577B2 (ja) * | 1990-06-15 | 1998-10-08 | エーザイ株式会社 | 環状アミド誘導体 |
| EP0475908A1 (de) * | 1990-09-14 | 1992-03-18 | Ciba-Geigy Ag | Chromogene Lactamverbindungen und ihre Herstellung und Verwendung |
| TW263504B (pl) | 1991-10-03 | 1995-11-21 | Pfizer | |
| TW248556B (pl) * | 1993-01-18 | 1995-06-01 | Takeda Pharm Industry Co | |
| US5620973A (en) * | 1993-11-30 | 1997-04-15 | Takeda Chemical Industries, Ltd. | Tetracyclic condensed heterocyclic compounds and their use |
| CN1572299A (zh) | 1998-09-30 | 2005-02-02 | 武田药品工业株式会社 | 改善膀胱排泄能力的药物 |
| ATE479686T1 (de) | 2002-10-30 | 2010-09-15 | Merck Frosst Canada Ltd | Pyridopyrrolizin- und pyridoindolizinderivate |
| US7662831B2 (en) | 2006-07-27 | 2010-02-16 | Wyeth Llc | Tetracyclic indoles as potassium channel modulators |
| US7601856B2 (en) | 2006-07-27 | 2009-10-13 | Wyeth | Benzofurans as potassium ion channel modulators |
| WO2012038966A1 (en) | 2010-09-22 | 2012-03-29 | Tyche Industries Ltd. | Process for the preparation of donepezil intermediate |
| JOP20200030A1 (ar) * | 2017-09-07 | 2020-02-12 | Eisai R&D Man Co Ltd | مركب خماسي الحلقة |
| EA202191966A1 (ru) | 2019-03-05 | 2021-12-08 | Эйсай Ар Энд Ди Менеджмент Ко., Лтд. | Пентациклическое гетероциклическое соединение |
| AU2020233452A1 (en) | 2019-03-05 | 2021-09-02 | Eisai R&D Management Co., Ltd. | Salt of pentacyclic compound and crystals thereof |
Family Cites Families (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US3910947A (en) * | 1969-07-24 | 1975-10-07 | Sandoz Ag | Preparation of imidazo{8 2,1-a{9 isoindoles |
| IT1199076B (it) * | 1984-03-01 | 1988-12-30 | Consiglio Nazionale Ricerche | Derivati della fisostigmina con proprieta'di inibizione della aceticolinesterasi e relativo procedimento di produzione |
| US4563469A (en) * | 1984-07-20 | 1986-01-07 | Warner-Lambert Company | Derivatives of N-[2-(tetrahydro-3,5-dioxo-1H-pyrrolizin-7a(5H)-yl)ethyl]amine as cognition activators |
| EP0187619A3 (de) * | 1985-01-03 | 1987-08-26 | Ciba-Geigy Ag | 1,3-disubstituierte Tetrahydropyridine |
| US4791107A (en) * | 1986-07-16 | 1988-12-13 | Hoechst-Roussel Pharmaceuticals, Inc. | Memory enhancing and analgesic 1,2,3,3A,8,8A-hexahydro-3A,8 (and) 1,3A,8)-di(and tri)methylpyrrolo(2,3-B)indoles, compositions and use |
| US4778812A (en) * | 1987-06-12 | 1988-10-18 | American Home Products Corporation | 2,3-dihydro-9-methyl-1H-pyrrolo[1,2-a]indol-1-amines and derivatives thereof |
| EP0351283A1 (fr) * | 1988-07-12 | 1990-01-17 | Synthelabo | Dérivés de [(pipéridinyl-4) méthyl]-2 dihydro-2,3 1H-isoindole et tétrahydro-2,3,4,5 1H-benzazépines, leur préparation et leur application en thérapeutique |
-
1991
- 1991-01-23 TW TW080100556A patent/TW197442B/zh active
- 1991-01-29 EP EP19910300662 patent/EP0441517A3/en not_active Withdrawn
- 1991-02-03 IL IL9714091A patent/IL97140A/en not_active IP Right Cessation
- 1991-02-06 PT PT96681A patent/PT96681A/pt unknown
- 1991-02-06 PL PL91304632A patent/PL167078B1/pl unknown
- 1991-02-06 CA CA002035805A patent/CA2035805C/en not_active Expired - Fee Related
- 1991-02-06 DE DE9101348U patent/DE9101348U1/de not_active Expired - Lifetime
- 1991-02-06 PL PL91288977A patent/PL166757B1/pl unknown
- 1991-02-07 BR BR919100519A patent/BR9100519A/pt not_active Application Discontinuation
- 1991-02-07 HU HU91406A patent/HUT70051A/hu unknown
- 1991-02-07 YU YU21391A patent/YU21391A/sh unknown
- 1991-02-07 IE IE040291A patent/IE910402A1/en unknown
- 1991-02-07 NO NO910473A patent/NO177534C/no unknown
- 1991-02-07 ZA ZA91916A patent/ZA91916B/xx unknown
- 1991-02-07 CS CS91299A patent/CS29991A2/cs unknown
- 1991-02-07 CN CN91100860A patent/CN1054600A/zh active Pending
- 1991-02-07 FI FI910592A patent/FI910592A/fi not_active Application Discontinuation
- 1991-02-07 KR KR1019910002113A patent/KR950013562B1/ko active IP Right Grant
- 1991-02-07 NZ NZ237040A patent/NZ237040A/xx unknown
- 1991-02-07 EG EG7591A patent/EG19644A/xx active
- 1991-02-07 AU AU70879/91A patent/AU631723B2/en not_active Ceased
- 1991-02-08 JP JP3103992A patent/JPH07119214B2/ja not_active Expired - Lifetime
Also Published As
| Publication number | Publication date |
|---|---|
| IL97140A (en) | 1995-07-31 |
| KR910015580A (ko) | 1991-09-30 |
| HUT70051A (en) | 1995-09-28 |
| PL167078B1 (pl) | 1995-07-31 |
| YU21391A (sh) | 1994-01-20 |
| HU910406D0 (en) | 1991-08-28 |
| FI910592A0 (fi) | 1991-02-07 |
| EP0441517A3 (en) | 1992-08-19 |
| PT96681A (pt) | 1991-10-31 |
| CN1054600A (zh) | 1991-09-18 |
| CS29991A2 (en) | 1991-09-15 |
| EP0441517A2 (en) | 1991-08-14 |
| IE910402A1 (en) | 1991-08-14 |
| BR9100519A (pt) | 1991-10-29 |
| NZ237040A (en) | 1993-10-26 |
| NO910473D0 (no) | 1991-02-07 |
| NO177534B (no) | 1995-06-26 |
| TW197442B (pl) | 1993-01-01 |
| PL288977A1 (en) | 1992-01-13 |
| JPH04234845A (ja) | 1992-08-24 |
| CA2035805C (en) | 1995-06-27 |
| PL166757B1 (pl) | 1995-06-30 |
| AU7087991A (en) | 1991-08-29 |
| JPH07119214B2 (ja) | 1995-12-20 |
| AU631723B2 (en) | 1992-12-03 |
| IL97140A0 (en) | 1992-05-25 |
| FI910592A (fi) | 1991-08-09 |
| EG19644A (en) | 1995-08-30 |
| ZA91916B (en) | 1992-09-30 |
| KR950013562B1 (ko) | 1995-11-09 |
| DE9101348U1 (de) | 1991-06-06 |
| NO910473L (no) | 1991-08-09 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| NO179448C (no) | Analogifremgangsmåte for fremstilling av terapeutisk aktive forbindelser | |
| NO179584C (no) | Analogifremgangsmåte for fremstilling av terapeutisk aktive 2-acylaminotiazoler | |
| FI104170B1 (fi) | Menetelmä terapeuttisesti käyttökelpoisten 3-amidopyratsolijohdannaisten valmistamiseksi | |
| NO179283C (no) | Analogifremgangsmåte for fremstilling av terapeutisk aktive substituerte azoler | |
| NO175978C (no) | Analogifremgangsmåte for fremstilling av terapeutisk aktive bis-aza-bicykliske forbindelser | |
| NO175478C (no) | Analogifremgangsmåte for fremstilling av terapeutisk aktive diazepin-derivater | |
| FI930723A (fi) | Menetelmä terapeuttisesti aktiivisten tiatsolidiinijohdannaisten valmistamiseksi | |
| NO175528C (no) | Analogifremgangsmåte for fremstilling av terapeutisk aktive fenylacetamid-derivater | |
| NO914490L (no) | Analogifremgangsmaate for fremstilling av terapeutisk virksomme tricykliske forbindelser | |
| NO177534C (no) | Analogifremgangsmåte for fremstilling av terapeutisk aktive tricykliske aminer | |
| FI98461B (fi) | Menetelmä terapeuttisesti käyttökelpoisten yhdisteiden valmistamiseksi | |
| NO175781C (no) | Analogifremgangsmåte for fremstilling av terapeutisk aktive tetracykliske forbindelser | |
| NO174774C (no) | Analogifremgangsmåte for fremstilling av terapeutisk aktive benzodiazepiner | |
| NO174203C (no) | Analogifremgangsmåte for fremstilling av terapeutisk aktive | |
| FI903077A0 (fi) | Menetelmä valmistaa terapeuttisesti aktiivisia R(-)-3-kinuklidinolijohdannaisia | |
| FI911701A (fi) | Menetelmä terapeuttisesti käyttökelpoisten 2-substituoitujen alkyyli-3-karboksikarbapeneemien valmistamiseksi | |
| FI100799B (fi) | Menetelmä terapeuttisesti aktiivisten tetraliinijohdannaisten valmista miseksi | |
| NO179517C (no) | Fremgangsmåte for fremstilling av 8-klorkinolonderivater | |
| NO173541C (no) | Analogifremgangsmaate for fremstilling av terapeutisk aktive polycykliske aminer | |
| NO304428B1 (no) | AnalogifremgangsmÕte for fremstilling av terapeutisk aktive vinylazoler | |
| NO177710C (no) | Analogifremgangsmåte for fremstilling av terapeutisk aktive slektede analoger | |
| NO178577C (no) | Fremgangsmåte til fremstilling av cefalosporin | |
| NO179909C (no) | Analogifremgangsmåte for fremstilling av terapeutisk avtive 6-substituerte purinylpiperazinderivater | |
| FI914874A (fi) | Menetelmä uusien terapeuttisesti käyttökelpoisten C-3-ditioasetaalisubstituoitujen karbapeneemiyhdisteiden valmistamiseksi | |
| NO174196C (no) | Fremgangsmåte for fremstilling av omega-decenol |